Switch to:
GuruFocus articles
Headlines from internet
09:37AMBetter Buy: Biogen Inc. vs. Gilead Sciences Fool
Nov-17-17$313.97 (+0.00%)
01:43PMDenali Therapeutics Files Raise 100 Million Ipo Seekingalpha
07:17AMAcorda unveils royalty transactions valued at $53 million MarketWatch
06:09AMBiotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3 Zacks
Nov-15-17$310.28 (+0.19%)
06:40PMAnother Threat Biogens Ms Franchise Seekingalpha
Nov-14-17$309.69 (-1.91%)
03:44PMIonis Pharmaceuticals Inc. Sets Itself Up for Growth Fool
12:14PMDaily Pharma Scoop Heron Undervalued Theravance Submits Nda Nektar Continues Surge Seekingalpha
04:10AMTracking Seth Klarmans Baupost Group Holdings Q3 2017 Update Seekingalpha
Nov-13-17$315.71 (+1.7%)
11:24AMWhich Will Pfizer Buy? Biogen or Bristol-Myers Squibb Barron's
10:08AMWhich Will Pfizer Buy? Biogen or Bristol-Myers Squibb Barron's
09:37AMBill Gates makes $100 million personal investment to fight Alzheimer's cnbc
09:00AMCan Marijuana Cure Alzheimer's Disease? Fool
12:20AMDaily Pharma Scoop Neurocrine Upside Dynavax Gets Fda Nod Sage Soars Seekingalpha
07:21AMBetter Buy: Acadia Pharmaceuticals vs. Biogen Fool
Nov-10-17$310.44 (+0.15%)
09:58AMApplied Genetic Technologies Corp Forgotten Net Net Clear Upside Catalysts Seekingalpha
07:45AMIonis Pharmaceuticals' Earnings Results Fuel Volatility Fool
Nov-08-17$312.58 (-0.32%)
01:14PM6 Reasons Gilead Didn’t Overpay for Kite Barron's
12:01PMSarepta Therapeutics Will Continue Ride High Exondys 51s Success 2017 Seekingalpha
11:57AMA Bright Spot in Blemished Biotech Barron's
Nov-07-17$313.57 (-0.6%)
12:01PMDaily Pharma Scoop Anxious Time Dynavax Longs Vbl Therapeutics Gets Boost Roche Gets 2 Fda Seekingalpha
05:29AMValuation Dashboard Healthcare Update Seekingalpha
Nov-06-17$315.47 (+0.42%)
01:40PMBiogen Biib Report 24 Month Interim Analysis Prime Seekingalpha
Nov-03-17$314.14 (+1.53%)
02:17PMBiogen Biib Aducanumab 36 Month Data Prime Slideshow Seekingalpha
10:47AMPDL BioPharma (PDLI) Q3 Earnings Beat, Revenues Rise Y/Y Zacks
Nov-02-17$309.4 (-2%)
12:16PMAvexis Revolutionary Cure Sma1 Enters Phase Iii Trials Excitement Mounting Seekingalpha
Nov-01-17$315.73 (+1.31%)
05:26PMIs a Beat in Store for Ionis (IONS) This Earnings Season? Zacks
04:07PMBiotechs Behaving Badly Analysis Seekingalpha
01:58PMAcorda (ACOR) Q3 Earnings Lag Estimates, Revenues Up Y/Y Zacks
Oct-31-17$311.66 (-1.31%)
02:53PMTop Analyst Reports for Microsoft, Chevron & Intel Zacks
02:29PMIonis Down Big on Analyst Miss Fool
03:00AMBiotech Analysis Central Daily Pharma News October 30 2017 Seekingalpha
Oct-30-17$315.8 (+2.62%)
12:10PMInterested Rare Disease Segment Put Ionis Pharmaceuticals Shopping List 2017 Seekingalpha
12:04PMDaily Pharma Scoop Gileads Unappreciated Opportunity Mercks Keytruda Stumble Epizymes Seekingalpha
02:04PM3 ETFs to Watch on Biotech Earnings Zacks
09:30AMDaily Pharma Scoop Celgenes Big Fall Tesaro Varubi Approval Tgtx Midstage Success Seekingalpha
Oct-26-17$307.64 (-2.22%)
04:54PMThe Biggest Loser: Celgene Selloff is Worst in Years   Barron's
03:55PMCelgene: Short Sellers Stand Tall Barron's
12:04PMDaily Pharma Scoop Roches Investment Potential Sarepta Lifts Guidance Pfizer Restructuring Seekingalpha
11:19AMCelgene's Stock Is Getting Absolutely Torched -- Don't Panic, Yet theStreet
09:06AMKey Predictions for Q3 Earnings Reports of ABBV, MRK Zacks
03:22AMUpside Kroger Cramers Lightning Round 10 25 17 Seekingalpha
Oct-25-17$314.64 (-0.35%)
09:55PMVenator Materials, Biogen Idec, Corning: 'Mad Money' Lightning Round theStreet
02:47PMBiogen Q3 2017 Many Uncertainties Seekingalpha
02:41PMBiogen Inc Content With "Resilience" of Its Multiple Sclerosis Franchise Fool
02:09PMBiogen Analysis Q3 Recent Events Seekingalpha
12:24PMBiogen: Let’s Start All Over Again Barron's
12:05PMDaily Pharma Scoop Soliris New Indication Gileads Nash Data Keeps Synergy Seekingalpha
11:42AMRoche Buying Dip Seekingalpha
11:41AMBiogen Spin Bioverativ Shows Strong Performance Robust Potential Seekingalpha
08:01AMWhat's Biogen's Big Risk? Fool
07:07AMBiotech Stock Roundup: Biogen Tops Q3 Earnings, Gilead's CAR T Drug Gets FDA Nod Zacks
Oct-24-17$315.73 (-3.9%)
09:00PMIonis Pharmaceuticals Tumbles on Biogen's Miss: Buy or Sell? Fool
04:28PMClosing Bell: Stocks Surge on Strong Earnings Reports Across the Board theStreet
04:10PMBiogen Shares Down Amid Lower-Than-Expected Q3 Spinraza U.S. Sales theStreet
04:01PMPositive Earnings Drive Dow to New Record in Best Performance in a Month theStreet
03:21PMDaily Pharma Scoop Valeant Value Trap Agenus Upside Celgenes Potential Seekingalpha
01:00PMAlexion: How Do You Spell Relief? Barron's
12:19PMWhy Ionis Pharmaceuticals Inc. Slipped This Morning Fool
11:55AMWhy Biogen's Beat Wasn't Good Enough for It…Or the Biotech Sector Barron's
11:53AMBiogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up Zacks
11:16AMBiogen stock drops 7% on concerns about Spinraza revenue growth MarketWatch
11:05AMAnti Amyloid Approach Alzheimers Disease Failed Seekingalpha
09:35AMBiogen Inc 2017 Q3 Results Earnings Call Slides Seekingalpha
09:30AMCaterpillar, McDonald's and 3M Earnings Fuel Stock Rebound theStreet
09:03AMLilly (LLY) Beats on Q3 Earnings, Explores Sale of Elanco Zacks
07:33AMBad news for the S&P — this powerhouse of a sector may be poised for a cooldown MarketWatch
07:16AMBiogen shares rise 1.4% after Q3 profit, revenue beats MarketWatch
07:02AMUS companies are acting on climate despite Trump's policies: Survey cnbc
06:28AMBiogen (BIIB) Beats on Q3 Earnings and Revenue Zacks
06:05AMMcDonald's, Sears and Amazon - 5 Things You Must Know Before the Market Opens Tuesday theStreet
03:22AMEarningsWatch: Amazon, Alphabet and AMD form tech’s A list MarketWatch
02:03AMBiotech Analysis Central Daily Pharma News October 23 2017 Seekingalpha
Oct-23-17$328.55 (-2.82%)
10:37AMBiotech's Big Week: Did Citi Jump the Gun on Biogen? Barron's
10:04AMBig Biotech Crispr Game Novartis Vertex Lead Pack Seekingalpha
08:19AM3 Gene Therapy Stocks That Could Make You Rich Fool
07:10AMKey Predictions for Q3 Earnings Reports of LLY, BIIB, NVS Zacks
06:26PMFutures and Dollar Rise as Trump Narrows Down Pool for Next Fed Chair theStreet
11:38AMWizardry 2017 Magic Formula Large Cap Strategy Update 2017 Ytd Seekingalpha
10:00AMThird-Quarter U.S. Economic Growth to Reveal Hurricane Damage in Week Ahead theStreet
Oct-20-17$338.1 (-1.26%)
04:47PMThe Biggest Loser: Does Celgene Need to Pipe Up? Barron's
03:57PMAnother Regeneron Bear Is Born Barron's
10:55AMCelgene: No Surprise? It’s 10% Drop Says Different. Barron's
Oct-19-17$342.42 (-0.63%)
10:01AMBiotech Developer Stocks Best Wealth Builders Now Seekingalpha
08:19AMZacks Market Edge Highlights: Gilead, Biogen, Teva, AbbVie and Aetna Zacks
Oct-18-17$344.58 (+0.03%)
12:48PMDaily Pharma Scoop Azns Imfinzi Sbla Ablynx U S Ipo Teva Buy Seekingalpha
08:33AMBiogen (BIIB) Q3 Earnings: Will it Deliver a Beat Again? Zacks
06:32AMBiotech Stock Roundup: Exelixis Soars on Priority Review, FDA Panel Supports Spark Drug Zacks
Oct-17-17$344.47 (+2.62%)
11:03PMValue System Amgen Looks Undervalued Seekingalpha
06:33PMWhere to Find Value in Healthcare Stocks Zacks
05:11PMWhy Biogen Is a $400 Stock Barron's
04:13PMUnitedHealth and a Bipartisan Healthcare Deal Sends Dow, S&P 500 to Records theStreet
03:19PMBiogen’s stock gets a big boost from 2 upgrades a week before earnings MarketWatch
11:07AMUnitedHealth and Johnson & Johnson Lead Bruised Healthcare Sector to Gains theStreet
09:14AMGoldman, Morgan Stanley Gain on Earnings; Spirit Airlines Flies Barron's
07:32AM3 Drug Stocks Hitting 52-Week Highs: Are They Buys? Fool
Oct-16-17$335.68 (-0.58%)
11:21AMSanofi Upward Trajectory 2017 Seekingalpha
Oct-13-17$337.64 (+1.3%)
04:59PMRoche Allergan Approaches Alzheimers Seekingalpha
01:34PMAssessing Pipeline Alzheimers Disease Part Anti Amyloid Antibodies Seekingalpha
11:40AMDaily Pharma Scoop Seeking Alpha Interview Spark Adcom Nod Luxturna Pfizer Lyrica Approval Seekingalpha
Oct-12-17$333.31 (+0.04%)
11:36AMBiogen Underperformance Opportunity Seekingalpha
07:30AMWill Biotech Continue Boom Seekingalpha
Oct-11-17$333.19 (+0.11%)
03:41PMAbbVie: You’re Upgrading It…Now? Barron's
Oct-10-17$332.83 (+1.16%)
01:40PMA Short-Term Stock Pullback Is Coming - Here's How to Play Your Cards Right theStreet
12:24PMCharting the S&P 500’s break to ‘clear skies’ technical territory MarketWatch
12:00PMCharting the S&P 500’s break to ‘clear skies’ technical territory MarketWatch
08:34AMBiogen Upside Good Value Seekingalpha
07:37AMBetter Buy: Biogen Inc. vs. Celgene Fool
Oct-09-17$329.01 (+0.47%)
10:49AM4 Biotechs to Buy Before Q3 Earnings Barron's
08:00AM3 Things Biotech Learn Today October 7 2017 Seekingalpha
Oct-06-17$327.48 (+0.23%)
01:31PMBiogen Problems Strategy Make Avoid Seekingalpha
Oct-05-17$326.74 (+3.75%)
08:55PMValuation Dashboard Healthcare Update Seekingalpha
08:53AMBiogen's stock surges after Morgan Stanley boosts rating, price target MarketWatch
07:16AMMorning Movers: Constellation Brands Jumps, Biogen Bounces, Celgene Slips Barron's
Sep-21-17$315.03 (-1.24%)
11:39AMBiogen: Buy or Hold? Barron's
Sep-19-17$317.93 (-0.08%)
12:29PMBiotech Pharma Stocks Soak Bottom Seekingalpha
Aug-29-17$293.58 (+0.44%)
09:41AMTop Momentum Picks In Blue-Chip Health Care Seekingalpha
08:56AMWeek In Review: Columbia China Building $150 Million Hospital In Jiaxing Seekingalpha
Aug-25-17$285.06 (-0.14%)
11:13AMRoche Is Almost At The Finish Line Seekingalpha
Aug-24-17$285.45 (+0.99%)
02:28PMArray Biopharma: One Small-Cap Biotech That Should Be In Everyone's Portfolio Seekingalpha
08:26AMBiogen Maturing In Growth Seekingalpha
Aug-22-17$286.72 (+1.26%)
04:39PMDiagnosing Merck (Part 1 Of 2) Seekingalpha
09:13AMSarepta Therapeutics: Backing A Cure For Duchenne Muscular Dystrophy Seekingalpha
Aug-21-17$283.15 (+0.49%)
03:14PMSeeking Confirmations - U.S. Stock Market Seekingalpha
12:33PMThe Troubles Never End For Teva Seekingalpha
09:39AMBiotech Forum Daily Digest: Agio Pharmaceuticals Back In The Spotlight Seekingalpha
07:07AMTracking Jeffrey Ubben's ValueAct Portfolio - Q2 2017 Update Seekingalpha
Aug-17-17$284.42 (-3.28%)
02:07PMWhat's Up With Biogen? Barron's
Aug-16-17$294.08 (+2.14%)
11:18AMBiotech Forum Daily Digest: Revisiting Bellicum Pharmaceuticals Seekingalpha
Aug-14-17$286.05 (+0.84%)
12:15PMFibrogen And Galapagos Raise Lung Disease Hopes Seekingalpha
05:44AMA Portfolio Of Biotech Growth Seekingalpha
04:31AMTracking Seth Klarman's Baupost Group Holdings - Q2 2017 Update Seekingalpha
Aug-11-17$283.68 (+0.9%)
07:28AMSanofi's Zika Standoff: Bad Medicine? Seekingalpha
Aug-09-17$288.74 (-0.18%)
11:07AMValuation Dashboard: Healthcare - Update Seekingalpha
Aug-07-17$291.01 (+0.95%)
08:10AMBioverativ: What A Pipeline Seekingalpha
07:38AMBioverativ: Advancing Hemophilia Treatments Seekingalpha
Aug-04-17$288.27 (+0.76%)
11:20AMRegeneron: High Growth, High Valuation Seekingalpha
Aug-02-17$288 (-1.08%)
03:09PMPfizer: Why The Stock May Get Interesting Again Seekingalpha
09:41AMPharma Tightens Its Belt On Jobs As Markets Fall Seekingalpha
Jul-26-17$295.61 (+4.47%)
04:43PMBiogen Q2 2017 Results: Few Steps In The Right Direction Seekingalpha
03:51PMBiogen Positions Itself For The Future Seekingalpha
12:35PM2 Cheers For Biogen, Which May Be Good Enough To Allow Alpha Seekingalpha
10:46AMBiogen’s Short-Term Pain to Yield Long-Term Gain Barron's
Jul-25-17$282.96 (-0.61%)
04:10PMNektar Makes A Stride Forward In Resolving Autoimmune Diseases Seekingalpha
03:43PMSamsung Leaps Into Its First U.S. Biosimilars Battle Seekingalpha
03:12PMBiotech Bonanza: The Next Leg Up Seekingalpha
09:15AMBiogen Inc. 2017 Q2 - Results - Earnings Call Slides Seekingalpha
09:04AMMirror Mirror On The Wall Street, Who's The Fearest Of Them All? Seekingalpha
Jul-24-17$284.7 (+0.63%)
09:42AMBuyer's Basket: Weekly Picks, July 24th, 2017 Seekingalpha
07:41AMSnippet Roundup: A Lingering Lingo And 2 More U.S. Green Lights Seekingalpha
01:35AMThe Trump Rally Has Been Good: This Approach Is Better Seekingalpha
Jul-11-17$271.76 (-0.67%)
05:01PMAC Immune: A Compelling Speculative Investment Seekingalpha
Jul-10-17$273.58 (-0.13%)
12:57PMValuation Dashboard: Healthcare - Update Seekingalpha
Jul-07-17$273.93 (+0.72%)
10:23AMBig Cap Biopharma Ends The Half Year On A High Note Seekingalpha
Jul-06-17$271.96 (-2.07%)
01:45PMGreenblatt, Big And Hedged - A Winning Combo Seekingalpha
12:54AMBiotech Stocks: Renewed Price Interest By Market-Maker Clients Seekingalpha
Jun-29-17$271.88 (-1%)
03:51PMThe Stem Cell Revolution Seekingalpha
Jun-26-17$279.81 (-0.18%)
12:56PMBiotech Boom!: Overview And Company-By-Company Review Seekingalpha
Jun-20-17$266 (+2.1%)
03:38PMBiotech Is Well-Positioned To Outperform Seekingalpha
Jun-16-17$251.74 (-1.29%)
03:14PMWhy Celgene is Bucking #Biotech Weakness Today Barron's
May-16-17$257.64 (-0.34%)
01:58PMCelgene Sales And Pipeline Keeping Pace With Expectations Seekingalpha
10:02AMTracking Seth Klarman's Baupost Group Holdings - Q1 2017 Update Seekingalpha
06:00AM3 Things In Biotech You Should Learn Today: May 14, 2017 Seekingalpha
May-11-17$254.15 (-1.46%)
10:25PM3 Reasons To Prefer AbbVie Over Biogen Seekingalpha
May-10-17$257.92 (-1.29%)
01:11PMAlzheimer's Disease: 40 Years In The Wilderness Seekingalpha
May-08-17$260.42 (-0.66%)
09:55AMValuation Dashboard: Healthcare - Update Seekingalpha
May-05-17$262.15 (-2.4%)
11:41AMBig Sales by #Biogen CFO Don’t Deter Buying Barron's
May-04-17$268.6 (-1.02%)
11:58AMBiotech Bonanza - Approaching An Inflection Point Seekingalpha
08:45AMAnalysis Of AbbVie's Pipeline: What's Left Of Abbott's Biopharma Growth Opportunities? Seekingalpha
May-02-17$271.34 (+0.11%)
05:13PMNeurotrope Alzheimer's Trial Shows Top Line Efficacy In Hardest To Treat Patients Seekingalpha
May-01-17$271.03 (-0.07%)
11:41AMMorningstar: This Large Biotech Could Be The World's Best Stock Seekingalpha
Apr-28-17$271.21 (-1.94%)
02:50PMHow Low Can You Go? U.S. Pharma Already Shoulders Light Tax Burden Seekingalpha
Apr-27-17$276.57 (-1.22%)
02:08PMAmgen's Q1 Shows Challenges And Growth Opportunities Aplenty Seekingalpha
08:39AMBiogen's Spinraza Dazzles But Rivals Rally Seekingalpha
Apr-26-17$279.98 (-2.41%)
07:01AMWall Street Breakfast: Tax Day Comes Round Again Seekingalpha
Apr-25-17$286.89 (+3.62%)
04:06PMBiogen: Key Q1 2017 Insights Seekingalpha
12:51PMBiogen Jumps On Q1 Results: Analysis Seekingalpha
12:08PMBiogen: Stuck in a Rut? Barron's
09:18AM3 Things In Biotech You Should Learn Today: April 25, 2017 Seekingalpha
09:07AM#Biotech: 3 Things to Focus on as Biogen and Amgen Report Barron's
08:43AMBiogen Inc. 2017 Q1 - Results - Earnings Call Slides Seekingalpha
Apr-24-17$276.86 (+1.44%)
02:08PMHow Spinraza's pricey $750,000 price tag could impact Biogen's earnings (it reports Q1 earnings tomorrow) MarketWatch
09:31AMNovo Nordisk's New Hemophilia-B Drug Will Have A Hard Time Getting Through FDA Panel Seekingalpha
07:22AMCelgene And Biogen Earnings Could Make Or Break The Biotech Sector Seekingalpha
Apr-18-17$271.16 (-1.05%)
04:03PMFor $300M, Biogen Beefs Up Its Alzheimer's Attack Seekingalpha
Apr-17-17$274.05 (+0.8%)
08:50AMMaybe The World Should Spend More On Legal Drugs: Implications Seekingalpha
06:56AMWall Street Breakfast: Geopolitical Concerns Weigh On Markets Seekingalpha
Apr-14-17$271.88 (+0%)
09:59AM#Biogen Snaps Up a 'Rare Find' From BMS: Instinet Barron's
Apr-13-17$271.88 (+1.1%)
04:05AMInternational Moats Impress Seekingalpha
Apr-11-17$268.65 (-0.24%)
12:26PMLarge Cap Biotech Review Coming Into Earnings Season, Part 1 Seekingalpha
Apr-10-17$269.3 (+0.21%)
09:18AMIs Ionis Pharmaceuticals Ready To Pop? Seekingalpha

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat